Answers are grounded in this paper and cite their sources.
Retrospective cohort study links prolonged lymphopenia to higher in-hospital venous thromboembolism risk in respiratory virus infections, highlighting crosstalk between inflammation and thrombosis.
Background Lymphopenia, a marker of prolonged clearance of virus, has unclear association with venous thromboembolism (VTE) in respiratory virus infection. Objectives This study aims to explore the correlation between prolonged lymphopenia and the risk of in-hospital VTE in patients with respiratory virus infection. Methods Adult patients with laboratory-confirmed COVID-19 influenza and other respiratory virus infection from January 1, 2016, to December 31, 2023, were retrospectively recruited. The primary outcome was symptomatic VTE during hospitalization. Logistic regression and the Fine–Gray model for competing risks were performed to explore the association between lymphopenia and VTE. Correlations between lymphocyte counts and inflammation/coagulation factors were evaluated using the mixed-effects model. Results Among 4172 patients (2640 with COVID-19, 844 with influenza, and 688 with other respiratory virus infection), in-hospital VTE incidences were 5.04%, 2.61%, and 3.63%, respectively. Lymphocyte counts were negatively correlated with D-dimer levels in the VTE group among COVID-19 patients (β, −0.012; 95% CI, 0.020 to −0.003; P = .0061). Lymphopenia lasting for 4 to 7 days in COVID-19 (VTE incidence, 8.75%; adjusted odds ratio, 2.06; 95% CI, 1.07-3.96; P = .0312) and for 1 to 3 days in other respiratory virus infection (VTE incidence, 7.53%; adjusted odds ratio, 3.81; 95% CI, 1.15-12.69; P = .0291) significantly increased the VTE risk. Lymphocyte-related peripheral blood count ratios, including the monocyte-to-lymphocyte ratio, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio, were all significantly associated with VTE in COVID-19 patients (all P < .0001). Conclusion VTE events were associated with prolonged lymphopenia in hospitalized patients infected with SARS-CoV-2 or other respiratory viruses. Lymphocyte-related blood count ratios were associated with VTE occurrence in patients infected with SARS-CoV-2. This finding provided additional evidence of the crosstalk between lymphocyte-related inflammation after respiratory virus infection and coagulation.
No takes yet. Share an insight, caveat, or question.
Fan et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: